Marshall Wace’s Nuvectis Pharma NVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $475K | Buy |
63,613
+24,739
| +64% | +$185K | ﹤0.01% | 2035 |
|
|
2025
Q1 | $380K | Sell |
38,874
-85,697
| -69% | -$837K | ﹤0.01% | 2065 |
|
|
2024
Q4 | $674K | Buy |
124,571
+81,757
| +191% | +$442K | ﹤0.01% | 1783 |
|
|
2024
Q3 | $269K | Buy |
42,814
+8,946
| +26% | +$56.3K | ﹤0.01% | 2031 |
|
|
2024
Q2 | $214K | Sell |
33,868
-16,200
| -32% | -$103K | ﹤0.01% | 2072 |
|
|
2024
Q1 | $411K | Buy |
50,068
+25,255
| +102% | +$207K | ﹤0.01% | 1763 |
|
|
2023
Q4 | $207K | Sell |
24,813
-11,272
| -31% | -$94K | ﹤0.01% | 1663 |
|
|
2023
Q3 | $465K | Sell |
36,085
-5,690
| -14% | -$73.3K | ﹤0.01% | 1464 |
|
|
2023
Q2 | $667K | Buy |
+41,775
| New | +$667K | ﹤0.01% | 1498 |
|